Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Grapefruit Benefits

Women With Chest Pain Less Likely Then Men To Get Proper Treatment From Paramedics
Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital, according to new research from the University of Pennsylvania School of Medicine. Despite evidence showing that the drugs aspirin and nitroglycerin are important early interventions for people who may be having a heart attack, women don"t get them as often as male patients with the same types of symptoms, says a new study that will be presented Friday, May 15, 2009 at the Society for Academic Emergency Medicine"s annual conference.
generic viagra online
American Journal Of Men's Health Accepted To MEDLINE
The American Journal of Men"s Health (AJMH), published by SAGE, has been accepted for inclusion in MEDLINE, the premier bibliographic database of the U.S. National Library of Medicine (NLM), containing more than 16 million journal article citations.
News of the day
BioSante Pharmaceuticals Comments On Benefits Of Testosterone Use In HIV-Infected Women
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), which is developing a testosterone gel (LibiGel®) for the treatment of hypoactive sexual desire disorder (HSDD) in menopausal women, today commented on a paper published in the May 15, 2009 issue of AIDS, the Journal of the International AIDS Society, on the effect of testosterone in women infected with HIV. The peer-reviewed journal reported results of a randomized, placebo-controlled trial of testosterone in HIV-infected women indicating that long-term testosterone administration was well tolerated in HIV-infected women and resulted in significant improvement in body composition, bone mineral density (BMD), and quality of life indices.
Endocrinology

Bio Manufacturers Poised To Follow Senate Victory With House Win

"A veteran California lawmaker with ties to the biotechnology industry said she thinks her proposal to protect brand-name biologic makers has enough support to carry in the House Energy and Commerce Committee," Dow Jones Newswires/Wall Street Journal reports. The proposal, by Rep. Anna Eshoo, D-Calif., would protect brand-name biologic products from competition for 12 years. A similar proposal cleared the Senate health committee earlier this week. Opponents of the proposal include the White House, the Federal Trade Commission and consumer groups like the AARP, "the influential lobby for the elderly," which "said it was disappointed with the Senate committee"s vote and "has great difficulty supporting legislation that would delay the availability of safe, affordable generic biologic drugs and impede consumer access to these life-saving drugs."" Rep. Henry Waxman, D-Calif., chairman of the Energy and Commerce Committee, has proposed protecting trademark products for only five to seven years. "Any legislation will likely affect the bottom lines of biologic makers such as Amgen Inc., Johnson & Johnson and Genentech Inc., and the wallets of consumers," Dow Jones reports. The sweeping health reform plan released yesterday did not include language on biologics, but Eshoo plans to introduce an amendment this week (Favole, 7/14). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009